Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a Randomized Controlled Trial

NCT05172206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2025-03-28

No results posted yet for this study

Summary

Inpatient, multimodal rehabilitation represents one of the most important interventions in the disease management of post/long COVID. Different professional societies, including the German Society of Pneumology and the European Respiratory Society, recommend rehabilitation intervention to reduce the sequelae of COVID-19. However, from the perspective of science and practice, there are relevant areas that have been insufficiently investigated and are essential for the treatment success of post/long COVID patients:

* Differentiation of rehabilitation effects from natural recovery after COVID-19.
* Lack of personalized and symptom-based treatment approaches that can address the heterogeneity of symptoms in post/long COVID
* Lack of uniform, high-quality rehabilitation standards in post-/long-COVID.

Therefore, post-COVID patients will be recruited at several post-COVID practices around Germany and randomized to receive (A) a rehabilitation program or (B) usual care. The primary objective of this randomized controlled trial (RCT) is to investigate whether a 3-week symptom-oriented, inpatient, multidisciplinary rehabilitation intervention, whose content focus is standardized according to cluster assignment (fatigue, cognition, soma), has a positive effect on the quality of life (primary outcome) in post-COVID syndrome patients compared to a usual care group (standard outpatient care). All study participants will be provided with a continuous telemonitoring system (SaniQ app) throughout the study period. After the interventional phase, there will be a 3 months follow-up assessment to evaluate the maintenance effects of COVID rehabilitation.

Conditions

Interventions

OTHER

symptom-focused rehabilitation

Patients in this arm will be referred to a 3-week inpatient comprehensive rehabilitation program. Initially, patients will be classified into one out of three clusters namely: Cluster A (Fatigue), Cluster B (cognition), or Cluster C (physical). The content of the rehabilitation program will be individually adapted according to the patient's most relevant symptom cluster.

OTHER

usual care

Patients in this arm do not receive any intervention beyond usual care during the study phase. However, all patients in this group will get the opportunity to also receive a rehabilitation program after the study phase.

Sponsors & Collaborators

  • Bavarian State Office for Health and Food Safety

    collaborator UNKNOWN
  • Praxis im Zentrum Erlangen

    collaborator UNKNOWN
  • Pneumologen Lichterfelde Berlin

    collaborator UNKNOWN
  • Pneumopraxis Marburg

    collaborator UNKNOWN
  • COVID ambulance Philipps-University Marburg

    collaborator UNKNOWN
  • Pneumologie Elisenhof Munich

    collaborator UNKNOWN
  • COVID ambulance Pneumology LMU Munich

    collaborator UNKNOWN
  • COVID ambulance psychology LMU Munich

    collaborator UNKNOWN
  • University Clinic Augsburg

    collaborator UNKNOWN
  • COVID ambulance Schön Klinik Schönau

    collaborator UNKNOWN
  • Schön Klinik Berchtesgadener Land

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2024-01-25
Completion
2024-01-25

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05172206 on ClinicalTrials.gov